Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H29NO.ClH |
Molecular Weight | 323.901 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.OC(CCN1CCCCC1)(C2CCCC2)C3=CC=CC=C3
InChI
InChIKey=WBCWFMFZMRFRLT-UHFFFAOYSA-N
InChI=1S/C19H29NO.ClH/c21-19(18-11-5-6-12-18,17-9-3-1-4-10-17)13-16-20-14-7-2-8-15-20;/h1,3-4,9-10,18,21H,2,5-8,11-16H2;1H
CYCRIMINE is an antispasmodic drug used for the treatment of Parkinson's disease (PD). It binds the muscarinic acetylcholine receptor M1, effectively reducing levels of acetylcholine. This decrease in acetylcholine restores the normal dopamine-acetylcholine balance and relieves the symptoms of PD.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P11229 Gene ID: 1128.0 Gene Symbol: CHRM1 Target Organism: Homo sapiens (Human) Sources: http://www.druglib.com/activeingredient/cycrimine/ |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Pagitane Approved UseCycrimine is used for Parkinson's disease. Launch Date1952 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
||
|
NCI_THESAURUS |
C38149
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1201227
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
9RB4L4K895
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
59693
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
DTXSID101350219
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
101597
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
DBSALT000820
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
100000084675
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
C65360
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
126-02-3
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
204-764-8
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
SUB01530MIG
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
169452
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
m136
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | Merck Index | ||
|
235421
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | RxNorm |
ACTIVE MOIETY
SUBSTANCE RECORD